IRD Q1 2025 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+155.4% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$10M-227.2% margin

Net Income

-$8M-187.5% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$913,000

Balance Sheet

Total Assets

$48M

Total Liabilities

$43M

Stockholders' Equity

$5M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+155.4%
Gross Profit	$4M	$2M	+155.4%
Operating Income	-$10M	-$8M	-28.8%
Net Income	-$8M	-$7M	-15.3%